Ovarian Cancer Clinical Trial

Feasibility and Evaluation of a Self-care App to Enhance Purposeful Living

Summary

In this pilot study, ovarian cancer survivors will be enrolled and followed for six months to evaluate usage of an eHealth app called "Purposeful".

View Full Description

Full Description

This study will determine the feasibility and acceptability of Purposeful, the eHealth app. First, feasibility of enrolling ovarian cancer survivors to use Purposeful will be assessed. Secondly, the acceptability of the app among ovarian cancer survivors will be assessed, based on frequency of use and validated acceptability measures. Participants will be asked to complete other validated questionnaires so investigators may explore whether further research on the Purposeful app among ovarian cancer survivors is warranted. This will include correlations between use of the Purposeful app and the life purpose questionnaire score. Lastly, correlation between life purpose and quality of life in ovarian cancer survivors will be explored.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of ovarian cancer or treatment for ovarian cancer through the University of Michigan Gynecologic Oncology service
Completed primary treatment (either surgery alone or surgery + chemotherapy)
Ability to understand and the willingness to sign a written informed consent
Ability to speak and read English

Exclusion Criteria:

There are no additional exclusion criteria for participation in this study.

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

60

Study ID:

NCT04458168

Recruitment Status:

Active, not recruiting

Sponsor:

University of Michigan Rogel Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Michigan Rogel Cancer Center
Ann Arbor Michigan, 48109, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

60

Study ID:

NCT04458168

Recruitment Status:

Active, not recruiting

Sponsor:


University of Michigan Rogel Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.